Market Research Logo

North American Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET- F-18), Therapeutic (Beta Emitters – I-131, Alpha Emitters, Brachytherapy – Y-90)), by Application (Oncology, Cardiology) - Forecasts to 2020

North American Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET- F-18), Therapeutic (Beta Emitters – I-131, Alpha Emitters, Brachytherapy – Y-90)), by Application (Oncology, Cardiology) - Forecasts to 2020

The North American nuclear medicine/radiopharmaceuticals market is poised to reach USD 2.98 billion by 2020 from USD 1.97 billion in 2015, growing at a CAGR of 8.6% during the forecast period of 2015 to 2020.

Nuclear medicine is a specialized field of medicine that covers all aspects of the use of radioactive substances, through either injection or ingestion, for the diagnosis or treatment of diseases such as cancer, cardiovascular disease, and neurological diseases. The nuclear medicine/radiopharmaceuticals market is bifurcated into diagnostic and therapeutic segments. Radiopharmaceuticals in the diagnostics market are categorized as SPECT and PET, whereas radiopharmaceuticals in the therapeutics market are categorized as beta emitters, brachytherapy isotopes, and alpha emitters.

In 2015, the diagnostic segment accounted for the largest share of the North American nuclear medicine/radiopharmaceuticals market, by type. Moreover, the SPECT segment is expected to account for the largest share of the North American diagnostic nuclear medicine/radiopharmaceuticals market. This can be attributed to growing cancer patient population, increasing preference for SPECT procedures, advances in SPECT radioisotopes, and cyclotron-based Tc-99m generation. In addition, in 2015, the beta emitters segment is expected to account for the largest share of the North American therapeutic nuclear medicine/radiopharmaceuticals market, owing to heavy funding for research on beta emitters, new therapeutic radioisotopes, and reimbursement policies in favor of using radiopharmaceuticals for cancer therapy.

In 2015, the cardiology application accounts for the largest share of North American nuclear medicine/radiopharmaceuticals market for SPECT applications. This large share can be attributed to new hardware and software designs in SPECT, rising incidence rate of CVDs, and adoption of SPECT in new cardiac applications. The PET market is dominated by oncology applications owing to its accuracy, and preference of PET over conventional imaging. In 2015, the therapeutic market is dominated by thyroid applications. This large share of thyroid applications can be attributed to the factors such as non-invasive method for treatment, and growing incidence of thyroid cancer.

In 2015, U.S. is expected to account for the largest share of the North American nuclear medicine/radiopharmaceuticals market, followed by Canada. The U.S. market is also likely to witness the highest growth rate of the North American nuclear medicine/radiopharmaceuticals market in the coming years. The U.S.’s large share and high growth rate can be attributed to the focus on domestic production of Mo-99, the approval of new radiopharmaceuticals by the FDA in the U.S., FDA approval for alpha emitter, growing focus on therapeutic nuclear medicine as an alternative treatment in oncology, and growing incidence of thyroid cancer.

The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (agreements, collaborations, contracts, and partnerships, marketing and promotions, new product launches, expansions, acquisitions, funding and grants, patent coverage extensions, website launches, and license renewals) to increase their market shares and establish a strong foothold in the North American market.

Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of top players in the North American nuclear medicine/radiopharmaceuticals market. The report analyzes the North American nuclear medicine/radiopharmaceuticals, by type of isotopes, applications, and country
Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the North American nuclear medicine/radiopharmaceuticals market
Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various nuclear medicine products, applications, and technologies across countries
Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the North American nuclear medicine/radiopharmaceuticals market
Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the North American nuclear medicine/radiopharmaceuticals market


  • INTRODUCTION
    • OBJECTIVES OF STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH METHODOLOGY STEPS
    • SECONDARY AND PRIMARY RESEARCH METHODOLOGY
      • SECONDARY RESEARCH
      • PRIMARY RESEARCH
    • MARKET SIZE ESTIMATION METHODOLOGY
    • RESEARCH DESIGN
    • MARKET DATA VALIDATION AND TRIANGULATION
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
    • INTRODUCTION
    • CURRENT SCENARIO
    • FUTURE OUTLOOK
  • PREMIUM INSIGHTS
    • NORTH AMERICAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET
    • NORTH AMERICAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS DIAGNOSTIC MARKET, BY THERAPEUTIC AND SPECT APPLICATION
    • NORTH AMERICAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, BY COUNTRY
    • NORTH AMERICAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, BY TYPE (2015 VS. 2020)
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET SEGMENTATION
    • MARKET DYNAMICS
      • DRIVERS
        • Table ALPHA RADIOIMMUNOTHERAPY-BASED TARGETED CANCER TREATMENT DRIVING MARKET GROWTH
      • RESTRAINTS
        • Table REQUIREMENT OF HIGH CAPITAL INVESTMENTS AND SHORT HALF-LIFE OF RADIOPHARMACEUTICALS RESTRAINING MARKET GROWTH
      • OPPORTUNITIES
        • Table POTENTIAL RADIOISOTOPES IN THE PIPELINE TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES TO MARKET PLAYERS
      • CHALLENGES
        • Table SHUTDOWN OF NUCLEAR REACTORS IS A MAJOR CHALLENGE IN THIS MARKET
  • NORTH AMERICAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET: PIPELINE ASSESSMENT
    • INTRODUCTION
    • DIAGNOSTIC RADIOISOTOPES
      • Table DETAILS OF RADIOPHARMACEUTICALS FOR UPCOMING DIAGNOSTIC APPLICATIONS
    • THERAPEUTIC RADIOISOTOPES
      • Table DETAILS OF RADIOPHARMACEUTICALS FOR UPCOMING THERAPEUTIC APPLICATIONS
  • NORTH AMERICAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, BY TYPE
    • INTRODUCTION
      • Table NORTH AMERICA: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
    • DIAGNOSTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS
      • Table NORTH AMERICA: DIAGNOSTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
      • Table NORTH AMERICA: DIAGNOSTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • SPECT RADIOPHARMACEUTICALS
        • Table NORTH AMERICA: SPECT NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: SPECT NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: TECHNETIUM-99M NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: THALLIUM-201 NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: GALLIUM-67 NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: IODINE-123 NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: OTHER SPECT NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
      • PET RADIOPHARMACEUTICALS
        • Table NORTH AMERICA: PET NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: PET NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: FLUORINE-18 NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: RUBIDIUM-82 NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: OTHER PET NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
    • THERAPEUTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS
      • Table NORTH AMERICA: THERAPEUTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
      • Table NORTH AMERICA: THERAPEUTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • BETA EMITTERS
        • Table NORTH AMERICA: BETA EMITTER NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: BETA EMITTER NUCLEAR MEDICINE MARKET SIZE, BY ISOTOPE, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: IODINE-131 NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: YTTRIUM-90 NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: SAMARIUM-153 NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICAN RHENIUM-186 NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: LUTETIUM-177 NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: OTHER BETA EMITTER NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
      • ALPHA EMITTERS
        • Table NORTH AMERICA: ALPHA EMITTER NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
      • BRACHYTHERAPY
        • Table NORTH AMERICA: BRACHYTHERAPY NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: BRACHYTHERAPY NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: IODINE-125 NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: IRIDIUM-192 NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: PALLADIUM-103 NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: CESIUM-131 NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: OTHER BRACHYTHERAPY NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • NORTH AMERICAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, BY APPLICATION
    • INTRODUCTION
    • DIAGNOSTIC APPLICATIONS
      • SPECT APPLICATIONS
        • Table NORTH AMERICA: DIAGNOSTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS APPLICATIONS MARKET SIZE FOR SPECT ISOTOPES, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: DIAGNOSTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS APPLICATIONS MARKET SIZE FOR SPECT ISOTOPES, BY TYPE, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: DIAGNOSTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR CARDIOLOGY SPECT APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: DIAGNOSTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR LYMPHOMA SPECT APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: DIAGNOSTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR NEUROLOGY SPECT APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: DIAGNOSTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR THYROID SPECT APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: DIAGNOSTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR OTHER SPECT APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
      • PET APPLICATIONS
        • Table NORTH AMERICA: DIAGNOSTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR PET APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: DIAGNOSTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR PET APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: DIAGNOSTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR ONCOLOGY PET APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: DIAGNOSTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR CARDIOLOGY PET APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: DIAGNOSTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR NEUROLOGY PET APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NORTH AMERICA: DIAGNOSTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR OTHER PET APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
    • THERAPEUTIC APPLICATIONS
      • Table NORTH AMERICA: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
      • Table NORTH AMERICA: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
      • THYROID
        • Table NORTH AMERICA: THERAPEUTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR THYROID APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
      • BONE METASTASIS
        • Table NORTH AMERICA: THERAPEUTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR BONE METASTASIS, BY COUNTRY, 2013-2020 (USD MILLION)
      • LYMPHOMA
        • Table NORTH AMERICA: THERAPEUTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR LYMPHOMA, BY COUNTRY, 2013-2020 (USD MILLION)
      • ENDOCRINE TUMORS
        • Table NORTH AMERICA: THERAPEUTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR ENDOCRINE APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
      • OTHER THERAPEUTIC APPLICATIONS
        • Table NORTH AMERICA: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • NORTH AMERICAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET FOR PROCEDURAL VOLUME
    • INTRODUCTION
      • Table NORTH AMERICA: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET FOR PROCEDURAL VOLUME, BY TYPE, 2013-2020 (THOUSAND UNITS)
      • Table NORTH AMERICA: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET FOR PROCEDURAL VOLUME, BY COUNTRY, 2013-2020 (THOUSAND UNITS)
    • DIAGNOSTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET FOR PROCEDURAL VOLUME
      • Table NORTH AMERICA: DIAGNOSTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET FOR PROCEDURAL VOLUME, BY TYPE, 2013-2020 (THOUSAND UNITS)
      • SPECT RADIOPHARMACEUTICALS
        • Table NORTH AMERICA: SPECT NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET FOR PROCEDURAL VOLUME, BY TYPE, 2013-2020 (THOUSAND UNITS)
      • PET RADIOPHARMACEUTICALS
        • Table NORTH AMERICA: PET NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET FOR PROCEDURAL VOLUME, BY TYPE, 2013-2020 (THOUSAND UNITS)
    • THERAPEUTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET FOR PROCEDURAL VOLUME
      • Table NORTH AMERICA: THERAPEUTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET FOR PROCEDURAL VOLUME, BY TYPE, 2013-2020 (THOUSAND UNITS)
      • BETA EMITTERS
        • Table NORTH AMERICA: BETA EMITTERS NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET FOR PROCEDURAL VOLUME, BY TYPE, 2013-2020 (THOUSAND UNITS)
      • BRACHYTHERAPY
        • Table NORTH AMERICA: BRACHYTHERAPY NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET FOR PROCEDURAL VOLUME, BY TYPE, 2013-2020 (THOUSAND UNITS)
  • NORTH AMERICAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, BY COUNTRY
    • INTRODUCTION
      • Table NORTH AMERICA: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
    • DIAGNOSTIC MARKET
      • NORTH AMERICA
        • Table U.S.: DIAGNOSTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
        • Table U.S.: SPECT NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
        • Table U.S.: PET NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
        • Table U.S.: SPECT NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
        • Table U.S.: PET NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
        • Table CANADA: DIAGNOSTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
        • Table CANADA: SPECT NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
        • Table CANADA: PET NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
        • Table CANADA: SPECT NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
        • Table CANADA: PET NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
    • THERAPEUTIC MARKET
      • NORTH AMERICA
        • Table U.S.: THERAPEUTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
        • Table U.S.: BETA EMITTERS NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
        • Table U.S.: BRACHYTHERAPY NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
        • Table U.S.: THERAPEUTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
        • Table CANADA: THERAPEUTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
        • Table CANADA: BETA EMITTERS NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
        • Table CANADA: BRACHYTHERAPY NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
        • Table CANADA: THERAPEUTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • COMPETITIVE SITUATION AND TRENDS
      • INTRODUCTION
      • AGREEMENTS, COLLABORATIONS, CONTRACTS, AND PARTNERSHIPS
        • Table AGREEMENTS, COLLABORATIONS, CONTRACTS, AND PARTNERSHIPS, 2013-2016
      • MARKETING AND PROMOTIONS
        • Table MARKETING AND PROMOTIONS, 2013-2016
      • NEW PRODUCT LAUNCHES
        • Table NEW PRODUCT LAUNCHES, 2013-2016
      • EXPANSIONS
        • Table EXPANSIONS, 2013-2014
      • ACQUISITIONS
        • Table ACQUISITIONS, 2013-2016
      • OTHER STRATEGIES
        • Table OTHER STRATEGIES, 2013-2016
    • NORTH AMERICAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET: EMPIRICAL ASSESSMENT OF GROWTH STRATEGIES
      • ROUTE TO STRATEGIC GROWTH: ORGANIC AND INORGANIC GROWTH STRATEGIES
      • ORGANIC GROWTH STRATEGIES
      • INORGANIC GROWTH STRATEGIES
  • COMPANY PROFILES
    • INTRODUCTION
    • CARDINAL HEALTH, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • MALLINCKRODT PLC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENT
      • MNM VIEW
    • GE HEALTHCARE
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • LANTHEUS MEDICAL IMAGING, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BAYER HEALTHCARE
      • BUSINESS OVERVIEW
      • PRODUCT OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BRACCO IMAGING S.P.A
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • ECZACIBASI-MONROL NUCLEAR PRODUCTS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • NORDION, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • ADVANCED ACCELERATOR APPLICATIONS S.A.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • IBA MOLECULAR IMAGING
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
  • APPENDIX
    • DISCUSSION GUIDE
    • AVAILABLE CUSTOMIZATIONS
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • RELATED REPORTS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report